R3 Vascular Appoints Josh Smale as its Vice President of Global Clinical and Scientific Affairs R3 Vascular Inc. is pleased to announce the appointment of Josh Smale as its Vice President of Global Clinical and Scientific Affairs.

R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer